Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.56 -0.02 (-1.27%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Operating Leases (2022 - 2024)

Updated

Lexicon Pharmaceuticals' Operating Leases came in at $5.08 million for Q1 2024, down 3.5% from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Operating Leases (2022 - 2024) Analysis & Trends

At the end of FY2023, Lexicon Pharmaceuticals' Operating Leases was $5.27 million, down 2.9% from FY2022.

  • Going back by year, Operating Leases was $5.42 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Lexicon Pharmaceuticals 684.93 Mn 111.48 Mn 653,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 5.08 Mn
Dec 31, 2023 5.27 Mn
Sep 30, 2023 5.44 Mn
Dec 31, 2022 5.42 Mn
API Access

Lexicon Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=LXRX&period=max&api_key=YOUR_API_KEY